ArticleCrohn's & colitis 3602022

Switching From Reference Infliximab to Biosimilar CT-P13 Did Not Change Quality of Life in Stable Inflammatory Bowel Disease Patients.

Marieke J Pierik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.